Loading organizations...
§ Private Profile · Shanghai, Shanghai, China
Tianyikang Biotechnology focuses on medical research and the development and application of next-generation cell immunotherapy products.
Tianyikang Biotechnology's investors include Guangzhou Guofa Venture Capital, Hony Capital, Mpow Health Fund.
Tianyikang Biotechnology most recently raised Seed in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 9, 2026 | Seed | — | Guangzhou Guofa Venture Capital, Hony Capital, Mpow Health Fund | Announced |